The report is titled as ‘Permanent Birth Control Drugs Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the permanent birth control drugs market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. The permanent birth control drugs market is expected to grow at a significant rate in the near future.
The global permanent birth control drugs market in 2020 is estimated for more than US$ 38,161.4 Mn and expected to reach a value of US$ 62,857.4 Mn by 2028 with a significant CAGR of 6.4%.
Birth control is a method of preventing pregnancy using drugs or a device. It is also known as contraception and fertility control. In order to prevent pregnancy devices used in contraception interfere along with normal process of sperm-ovum fertilization.
Source: Department of Economic and Social Affairs Population Division 2015, United Nations
Increasing attention towards the prevention of unintended pregnancy and family planning is one of the major factors that are expected to prompt the growth of the permanent birth control drugs market around the globe. According to the centers for disease control and prevention, in 2017, it was estimated that about 194,377 babies were born to women, aged 15-19 years, for a birth rate of 18.8 per 1,000 women, in this age group.
In addition, the increase in the use of contraception in young women along with the rise in higher educational attainment propels the target market growth.
Furthermore, health problems linked with under-age pregnancies can be reduced due to the increase in popularity of new era’s contraception methods, and the increase of contraceptive oral pills use as an important method to avoid unplanned pregnancy, which further boosts the growth in the global contraceptives market.
Moreover, government initiatives to spread awareness regarding population control is expected to support the growth of the target market in the near future.
However, risks related to the human health of using contraceptives, availability of alternate contraceptive methods, and lack of social acceptance is expected to undermine the growth of the permanent birth control drugs market.
The permanent birth control drugs market is segmented on the basis of product, age group, education, end-user, and by region.
By Product
Drugs
Devices
Intrauterine Devices (IUDs)
Hormonal IUDs
Copper IUDs
Diaphragms
Sponges
Patches
Implants
Vaginal Rings
Others
By Age Group
15‐24 years
25‐34 years
35‐44 years
Above 44 years
By Education
Less than high school
High school graduate
College graduate
Other college degrees
By End User
Household
Hospitals
Clinics
By Region
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Some of the key participating players in the global permanent birth control drugs market are The Female Health Company, Teva Pharmaceutical Industries Limited, Mayer Laboratories Allergan plc, Bayer AG, Pfizer, Inc., Cooper Companies, Inc., Ansell LTD., Merck & Co., Inc., and Church & Dwight, Co., Inc.
On the basis of region, the permanent birth control drugs market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the Permanent Birth Control Drugs market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
• New product designs and launches
• Current product compliance
• Reimbursement
• Concerns for use of Permanent Birth Control Drugs
• Advantages of Permanent Birth Control Drugs
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
1. Global Permanent Birth Control Drugs Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Permanent Birth Control Drugs Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Permanent Birth Control Drugs Market Snapshot
2.4. Global Permanent Birth Control Drugs Market Size and Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Permanent Birth Control Drugs Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Permanent Birth Control Drugs Market, By Product
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Product
3.1.2. BPS Analysis, By Product
3.2. Market Revenue (US$Mn) Forecast, By Product
3.2.1. Drugs
3.2.2. Devices
3.2.2.1. Intrauterine Devices (IUDs)
3.2.2.2. Hormonal IUDs
3.2.2.3. Copper IUDs
3.2.3. Diaphragms
3.2.4. Sponges
3.2.5. Patches
3.2.6. Implants
3.2.7. Vaginal Rings
3.2.8. Others
3.3. Global Permanent Birth Control Drugs Market Attractiveness Index, By Product
4. Global Permanent Birth Control Drugs Market, By Age Group
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Age Group
4.1.2. BPS Analysis, By Age Group
4.2. Market Revenue (US$Mn) Forecast, By Age Group
4.2.1. 15‐24 years
4.2.2. 25‐34 years
4.2.3. 35‐44 years
4.2.4. Above 44 years
4.3. Global Permanent Birth Control Drugs Market Attractiveness Index, By Age Group
5. Global Permanent Birth Control Drugs Market, By Education
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Education
5.1.2. BPS Analysis, By Education
5.2. Market Revenue (US$Mn) Forecast, By Education
5.2.1. Less Than High School
5.2.2. High School Graduate
5.2.3. College Graduate
5.2.4. Other College Degrees
5.3. Global Permanent Birth Control Drugs Market Attractiveness Index, By Education
6. Global Permanent Birth Control Drugs Market, By End User
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By End User
6.1.2. BPS Analysis, By End User
6.2. Market Revenue (US$Mn) Forecast, By End User
6.2.1. Household
6.2.2. Hospitals
6.2.3. Clinics
6.3. Global Permanent Birth Control Drugs Market Attractiveness Index, By End User
7. Global Permanent Birth Control Drugs Market, By Region
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Region
7.1.2. BPS Analysis, By Region
7.2. Market Revenue (US$Mn) Forecast, By Region
7.2.1. North America
7.2.2. Latin America
7.2.3. Europe
7.2.4. Asia Pacific
7.2.5. Middle East
7.2.6. Africa
7.3. Global Permanent Birth Control Drugs Market Attractiveness Index, By Region
8. North America Permanent Birth Control Drugs Market Analysis and Forecast, 2020–2028
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market Revenue (US$Mn) Forecast, By Country
8.2.1. U.S. Permanent Birth Control Drugs Market
8.2.2. Canada Permanent Birth Control Drugs Market
8.3. North America Permanent Birth Control Drugs Market, By Product
8.3.1. Drugs
8.3.2. Devices
8.3.2.1. Intrauterine Devices (IUDs)
8.3.2.2. Hormonal IUDs
8.3.2.3. Copper IUDs
8.3.3. Diaphragms
8.3.4. Sponges
8.3.5. Patches
8.3.6. Implants
8.3.7. Vaginal Rings
8.3.8. Others
8.4. North America Permanent Birth Control Drugs Market, By Age Group
8.4.1. 15‐24 years
8.4.2. 25‐34 years
8.4.3. 35‐44 years
8.4.4. Above 44 years
8.5. North America Permanent Birth Control Drugs Market, By Education
8.5.1. Less Than High School
8.5.2. High School Graduate
8.5.3. College Graduate
8.5.4. Other College Degrees
8.6. North America Permanent Birth Control Drugs Market, By End User
8.6.1. Household
8.6.2. Hospitals
8.6.3. Clinics
8.7. North America Permanent Birth Control Drugs Market Attractiveness Index
8.7.1. By Country
8.7.2. By Product
8.7.3. By Age Group
8.7.4. By Education
8.7.5. By End User
9. Latin America Permanent Birth Control Drugs Market Analysis and Forecast, 2020–2028
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. Brazil Permanent Birth Control Drugs Market
9.2.2. Mexico Permanent Birth Control Drugs Market
9.2.3. Argentina Permanent Birth Control Drugs Market
9.2.4. Rest of Latin America Permanent Birth Control Drugs Market
9.3. Latin America Permanent Birth Control Drugs Market, By Product
9.3.1. Drugs
9.3.2. Devices
9.3.2.1. Intrauterine Devices (IUDs)
9.3.2.2. Hormonal IUDs
9.3.2.3. Copper IUDs
9.3.3. Diaphragms
9.3.4. Sponges
9.3.5. Patches
9.3.6. Implants
9.3.7. Vaginal Rings
9.3.8. Others
9.4. Latin America Permanent Birth Control Drugs Market, By Age Group
9.4.1. 15‐24 years
9.4.2. 25‐34 years
9.4.3. 35‐44 years
9.4.4. Above 44 years
9.5. Latin America Permanent Birth Control Drugs Market, By Education
9.5.1. Less Than High School
9.5.2. High School Graduate
9.5.3. College Graduate
9.5.4. Other College Degrees
9.6. Latin America Permanent Birth Control Drugs Market, By End User
9.6.1. Household
9.6.2. Hospitals
9.6.3. Clinics
9.7. Latin America Permanent Birth Control Drugs Market Attractiveness Index
9.7.1. By Country
9.7.2. By Product
9.7.3. By Age Group
9.7.4. By Education
9.7.5. By End User
10. Europe Permanent Birth Control Drugs Market Analysis and Forecast, 2020–2028
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. U.K. Permanent Birth Control Drugs Market
10.2.2. Germany Permanent Birth Control Drugs Market
10.2.3. Italy Permanent Birth Control Drugs Market
10.2.4. France Permanent Birth Control Drugs Market
10.2.5. Spain Permanent Birth Control Drugs Market
10.2.6. Russia Permanent Birth Control Drugs Market
10.2.7. Poland Permanent Birth Control Drugs Market
10.2.8. BENELUX Permanent Birth Control Drugs Market
10.2.9. NORDIC Permanent Birth Control Drugs Market
10.2.10. Rest of Europe Permanent Birth Control Drugs Market
10.3. Europe Permanent Birth Control Drugs Market, By Product
10.3.1. Drugs
10.3.2. Devices
10.3.2.1. Intrauterine Devices (IUDs)
10.3.2.2. Hormonal IUDs
10.3.2.3. Copper IUDs
10.3.3. Diaphragms
10.3.4. Sponges
10.3.5. Patches
10.3.6. Implants
10.3.7. Vaginal Rings
10.3.8. Others
10.4. Europe Permanent Birth Control Drugs Market, By Age Group
10.4.1. 15‐24 years
10.4.2. 25‐34 years
10.4.3. 35‐44 years
10.4.4. Above 44 years
10.5. Europe Permanent Birth Control Drugs Market, By Education
10.5.1. Less Than High School
10.5.2. High School Graduate
10.5.3. College Graduate
10.5.4. Other College Degrees
10.6. Europe Permanent Birth Control Drugs Market, By End User
10.6.1. Household
10.6.2. Hospitals
10.6.3. Clinics
10.7. Europe Permanent Birth Control Drugs Market Attractiveness Index
10.7.1. By Country
10.7.2. By Product
10.7.3. By Age Group
10.7.4. By Education
10.7.5. By End User
11. Asia Pacific Permanent Birth Control Drugs Market Analysis and Forecast, 2020–2028
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) Forecast, By Country
11.2.1. China Permanent Birth Control Drugs Market
11.2.2. India Permanent Birth Control Drugs Market
11.2.3. Japan Permanent Birth Control Drugs Market
11.2.4. Australia and New Zealand Permanent Birth Control Drugs Market
11.2.5. South Korea Permanent Birth Control Drugs Market
11.2.6. ASEAN Permanent Birth Control Drugs Market
11.2.7. Rest of Asia Pacific Permanent Birth Control Drugs Market
11.3. Asia Pacific Permanent Birth Control Drugs Market, By Product
11.3.1. Drugs
11.3.2. Devices
11.3.2.1. Intrauterine Devices (IUDs)
11.3.2.2. Hormonal IUDs
11.3.2.3. Copper IUDs
11.3.3. Diaphragms
11.3.4. Sponges
11.3.5. Patches
11.3.6. Implants
11.3.7. Vaginal Rings
11.3.8. Others
11.4. Asia Pacific Permanent Birth Control Drugs Market, By Age Group
11.4.1. 15‐24 years
11.4.2. 25‐34 years
11.4.3. 35‐44 years
11.4.4. Above 44 years
11.5. Asia Pacific Permanent Birth Control Drugs Market, By Education
11.5.1. Less Than High School
11.5.2. High School Graduate
11.5.3. College Graduate
11.5.4. Other College Degrees
11.6. Asia Pacific Permanent Birth Control Drugs Market, By End User
11.6.1. Household
11.6.2. Hospitals
11.6.3. Clinics
11.7. Asia Pacific Permanent Birth Control Drugs Market Attractiveness Index
11.7.1. By Country
11.7.2. By Product
11.7.3. By Age Group
11.7.4. By Education
11.7.5. By End User
12. Middle East Permanent Birth Control Drugs Market, By Region
12.1. Introduction
12.1.1. Annual Growth Rate Comparison, By Country
12.1.2. BPS Analysis, By Country
12.2. Market (US$Mn) Forecast, By Country
12.2.1. GCC Countries Permanent Birth Control Drugs Market
12.2.2. Israel Permanent Birth Control Drugs Market
12.2.3. Oman Permanent Birth Control Drugs Market
12.2.4. Rest of Middle East Permanent Birth Control Drugs Market
12.3. Middle East Permanent Birth Control Drugs Market, By Product
12.3.1. Drugs
12.3.2. Devices
12.3.2.1. Intrauterine Devices (IUDs)
12.3.2.2. Hormonal IUDs
12.3.2.3. Copper IUDs
12.3.3. Diaphragms
12.3.4. Sponges
12.3.5. Patches
12.3.6. Implants
12.3.7. Vaginal Rings
12.3.8. Others
12.4. Middle East Permanent Birth Control Drugs Market, By Age Group
12.4.1. 15‐24 years
12.4.2. 25‐34 years
12.4.3. 35‐44 years
12.4.4. Above 44 years
12.5. Middle East Permanent Birth Control Drugs Market, By Education
12.5.1. Less Than High School
12.5.2. High School Graduate
12.5.3. College Graduate
12.5.4. Other College Degrees
12.6. Middle East Permanent Birth Control Drugs Market, By End User
12.6.1. Household
12.6.2. Hospitals
12.6.3. Clinics
12.7. Middle East Permanent Birth Control Drugs Market Attractiveness Index
12.7.1. By Country
12.7.2. By Product
12.7.3. By Age Group
12.7.4. By Education
12.7.5. By End User
13. Africa Permanent Birth Control Drugs Market, By Region
13.1. Introduction
13.1.1. Annual Growth Rate Comparison, By Country
13.1.2. BPS Analysis, By Country
13.2. Market (US$Mn) Forecast, By Country
13.2.1. South Africa Permanent Birth Control Drugs Market
13.2.2. Egypt Permanent Birth Control Drugs Market
13.2.3. North Africa Permanent Birth Control Drugs Market
13.2.4. Rest of Africa Permanent Birth Control Drugs Market
13.3. Africa Permanent Birth Control Drugs Market, By Product
13.3.1. Drugs
13.3.2. Devices
13.3.2.1. Intrauterine Devices (IUDs)
13.3.2.2. Hormonal IUDs
13.3.2.3. Copper IUDs
13.3.3. Diaphragms
13.3.4. Sponges
13.3.5. Patches
13.3.6. Implants
13.3.7. Vaginal Rings
13.3.8. Others
13.4. Africa Permanent Birth Control Drugs Market, By Age Group
13.4.1. 15‐24 years
13.4.2. 25‐34 years
13.4.3. 35‐44 years
13.4.4. Above 44 years
13.5. Africa Permanent Birth Control Drugs Market, By Education
13.5.1. Less Than High School
13.5.2. High School Graduate
13.5.3. College Graduate
13.5.4. Other College Degrees
13.6. Africa Permanent Birth Control Drugs Market, By End User
13.6.1. Household
13.6.2. Hospitals
13.6.3. Clinics
13.7. Africa Permanent Birth Control Drugs Market Attractiveness Index
13.7.1. By Country
13.7.2. By Product
13.7.3. By Age Group
13.7.4. By Education
13.7.5. By End User
14. Recommendation
14.1. Market Strategy
15. Competitive Landscape
15.1. Competition Dashboard
15.2. List and Company Overview of Global Key Players
15.3. Company Profiles
15.3.1. The Female Health Company
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Component Portfolio
15.3.1.4. Key Developments
15.3.1.5. Business Strategies
15.3.2. Teva Pharmaceutical Industries Limited
15.3.3. Mayer Laboratories
15.3.4. Allergan plc
15.3.5. Bayer AG
15.3.6. Pfizer, Inc.
15.3.7. Cooper Companies, Inc.
15.3.8. Ansell LTD.
15.3.9. Merck & Co., Inc.
15.3.10. Church & Dwight, Co., Inc.
16. Acronyms
